Envista Holdings (NVST)
NYSEHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-04
$24.96-8.20%
Close 2026-11-05 · 1-day change
NYSEHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-04
QuarterlyIQ Insights · NVST
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | 2,878.1 | 2,719.5 | 2,510.6 | 2,566.5 | 2,569.1 | 2,508.9 | 1,929.1 | 2,284.8 |
| Total Revenues | — | — | — | 2,566.5 | 2,569.1 | 2,508.9 | 1,929.1 | 2,284.8 |
| Cost of Revenues | 1,269.8 | 1,232.8 | 1,137.9 | 1,126.0 | 1,094.3 | 1,082.4 | 874.3 | 935.6 |
| Gross Profit | 1,608.3 | 1,486.7 | 1,372.7 | 1,440.5 | 1,474.8 | 1,426.5 | 1,054.8 | 1,349.2 |
| Operating Expenses & Income | ||||||||
| Selling, General & Admin | 1,183.3 | 1,156.6 | 1,158.0 | 1,056.9 | 1,055.5 | 1,019.8 | 924.6 | 980.4 |
| R&D Expenses | 121.8 | 114.0 | 99.1 | 93.8 | 100.1 | 100.5 | 86.7 | 133.1 |
| Operating Income | 731.3 | 216.1 | (1,038.2) | 31.5 | 319.2 | 306.2 | 43.5 | 235.7 |
| Earnings from Continuing Operations | ||||||||
| Interest Expense | — | — | — | 63.4 | 38.4 | 54.1 | 62.5 | 3.5 |
| EBT, Incl. Unusual Items | 684.4 | 177.2 | (1,084.7) | (54.9) | 283.9 | 254.5 | (20.0) | 233.7 |
| Income Tax Expense | 50.8 | 130.2 | 33.9 | 45.3 | 45.9 | (9.0) | (62.5) | 49.6 |
| Net Income | ||||||||
| Net Income | 633.6 | 47.0 | (1,118.6) | (100.2) | 243.1 | 340.5 | 33.3 | 217.6 |
| Per Share | ||||||||
| Basic EPS | 3.94 | 0.28 | (6.50) | (0.60) | 1.49 | 2.11 | 0.21 | 1.60 |
| Diluted EPS | 3.88 | 0.28 | (6.50) | (0.60) | 1.37 | 1.92 | 0.20 | 1.60 |
| Revenue per Share | 17.61 | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 160.8 | 168.0 | 172.2 | 166.9 | 162.9 | 161.2 | 159.6 | 136.2 |
| Diluted Weighted Avg Shares | 163.4 | 169.2 | 172.2 | 166.9 | 177.6 | 177.6 | 164.1 | 136.4 |
| Supplemental | ||||||||
| EBITDA | — | 332.1 | (915.1) | 167.1 | 457.0 | 424.0 | 165.2 | 356.1 |
| EBIT | 731.3 | 216.1 | (1,038.2) | 31.5 | 319.2 | 306.2 | 43.5 | 235.7 |
| Effective Tax Rate | 7.4% | — | — | -82.5% | 16.2% | -3.5% | 312.5% | 21.2% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.